Nextblockbuster, the last time I checked (?? 8 month ago) Don was receiving a salary of just under $100,000.

Dr Lakhotia, vp business development, was being paid roughly $500,000. That's partly why I think Dr Lakhotia and his team are making things happens at ZE. He has the science, the MBA, the business skills and progress at ZE has been continuous and effectively structured.

After listening to Don's presentation I realized more than ever I have hitched my wagon to the wrong donkey.

Perhaps some of the nonsense that Don is spouting may come true (ZCC royalties). I believe that the reason that he spent so much time on RVX science and ZE achievements is because him and his team have achieved nothing in terms of their jobs ...financing.

Don's entire presentation was excuses for why he is failing in his efforts. This is not the sign of a winning leader. One thing he said was that Zenith has it easy because of all of the indications (cancers) it is applicable too. I recall apabetalone has a long list of indications (CVD, CKD, Covid, HIV, etc) that should be funded in the Zenith manner. Just let Dr Lakhotia take over RVX. Or, bring in a competent CEO. Bring in Lloyd Segal (or his equivalent) of SNPIRx and instant wealth will be created.

The follow up posts have been excellent. I always appreciate the posts with some positive spin. However, this presentation has convinced me once and for all that Don is a snake oil saleman in in charge of trying to sell a golden egg and he does not have a clue what to do.

IMO shareholders wil not see any value in RVX until a competent CEO is appointed.

Sorry for the rant but "Pinnochio" did it again. I remain long because of the "golden egg".

GLTA

Toinv